SGI is now giving SGI Altix customers a free, one-year subscription to Interactive Supercomputings (ISC) Star-P, an interactive desktop tool for rapidly solving large scientific and engineering problems.
GenoLogics, a developer of lab and scientific data management solutions, has completed a second round of financing led by OVP Venture Partners in Seattle.
DEM Solutions, a leading developer of DEM (discrete element method) software solutions, has opened a US office in Lebanon, New Hampshire.
ClinPhone has acquired DataLabs, an electronic data capture (EDC) vendor, enabling ClinPhone to offer a comprehensive suite of clinical trial management and data capture systems.
Users of the new PerkinElmer Clarus 600 GC/MS will have the option to incorporate Ion Signature Quantitative Deconvolution Software for fast and accurate data review and evaluation.
InforSense, a provider of enterprise real-time analytics and Thermo Electron Corporation, a provider of analytical instruments, have announced a three-year OEM agreement, to integrate InforSense KDE and BioWorks.
A new study of more than 500 users, sponsored by Interactive Supercomputing, suggests difficulties in programming is increasingly becoming one of researchers biggest productivity killers.
The Numerical Mathematics Consortium has announced the latest revision to a technical specification that will resolve technical issues and includes the addition of new function definitions.
InforSense has received an investment of $10m, led by two of its largest investors, Fleming Family & Partners (FF&P) and Imperial Innovations Group.
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
